Stereotaxis has launched the Synchrony system for cath laboratories after receiving 510(k) clearance from the FDA.

Shares of Stereotaxis rose after the company said its Synchrony system had received clearance from the Food and Drug Administration. Shares were up 5.4% to $1.97 in Monday morning trading. The stock ...

The St. Louis-based developer of surgical robotic technology for minimally invasive endovascular intervention designed its ...

Researchers at the University of California, Irvine, have developed a polymeric biohybrid cardiac device that harnesses the power of light to electrically and mechanically control living heart tissue ...

The placement device for the LivIQ leadless pacemaker. [Image courtesy of Biotronik] Biotronik today announced the initiation of a global pivotal study evaluating its LivIQ leadless pacemaker. The ...

International BIO-LivIQ Study Will Generate Evidence for Global LivIQ Leadless Pacemaker Approvals Far-Field Sensing and AV-Synchronous Pacing Performance Will be Validated by Real World Clinical Data ...

Synchrony Financial (NYSE:SYF) is among the 10 Unstoppable Stocks to Buy and Hold for the Next 3 Years. Synchrony Financial (NYSE:SYF) is one of the Unstoppable Stocks to Buy and Hold for the Next 3 ...

Can AI help neurodivergent adults connect with each other? That’s the bet of a new social network called Synchrony, which believes AI and a well-designed social network with the right safeguards can ...

STAMFORD, Conn., Feb. 3, 2026 /PRNewswire/ -- Synchrony (NYSE: SYF) Chief Financial Officer, Brian J. Wenzel, will participate in a fireside chat at the 2026 UBS Financial Services Conference on ...